People | January 17, 2022
SeQuent Scientific appoints Rajaram Narayanan as MD & CEO
Narayanan to lead SeQuent through next phase of consolidation and growth
Narayanan to lead SeQuent through next phase of consolidation and growth
The new plant at Slovenská ?up?a site in Slovakia is scheduled to come on stream in two years
The stability is led by healthy demand in the domestic and emerging markets
This surpasses the number of approvals supported in 2020
First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC
Acquisition adds Adaptate’s novel antibody-based ?? T-cell engager platform to Takeda’s Immuno-oncology portfolio built around the Innate Immune System
Health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the case of high-risk patients
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma
Under the terms of the agreement, Mammoth Biosciences will receive an upfront payment of USD 40 million, potential future payments of more than one billion USD upon successful achievement of certain research, development, and commercial milestones
Six months after receipt of the second Covaxin dose, participants received booster dose of the same. The trial demonstrated long-term safety with no serious events
Subscribe To Our Newsletter & Stay Updated
